Skip to main content
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 1990 Dec 1;68(23):1183–1188. doi: 10.1007/BF01815277

Complications of plasma exchange in patients with neurological diseases

Th Henze 1, H W Prange 1, J Talartschik 2, K W Rumpf 2
PMCID: PMC7096018  PMID: 2280582

Summary

Plasma exchange has proven to be effective in diseases of established or presumed autoimmune etiology as well as in hyperviscosity syndromes and some rare metabolic disorders. Its application is thought to be relatively safe; nevertheless, severe complications may occur. We therefore analyzed the complications of 291 exchanges in 39 patients with neurological diseases. Minor complications developed in 4.8% and major complications in 2.7% of procedures, including one death. Severe infections and technical problems have been the most serious side effects, sometimes followed by organ failure or even death.

Key words: Plasma exchange, Complications, Neurological diseases

Abbreviations

ARDS

adult respiratory distress syndrome

FFP

fresh frozen plasma

GBS

Guillain-Barré syndrome

LDL

low density lipoproteins

MS

multiple sclerosis

MG

myasthenia gravis

PNP

polyneuropathy

References

  • 1.Boucher CAB, deGans J, van Oers R, Danner S, Goudsmit J. Transmission of HIV and AIDS by plasmapheresis for Guillain-Barré Syndrome. Clin Neurol Neurosurg. 1988;90:235–236. doi: 10.1016/0303-8467(88)90027-3. [DOI] [PubMed] [Google Scholar]
  • 2.French Cooperative Group on Plasma Exchange in Guillain-Barré Syndrome Efficiency of plasma exchange in Guillain-Barré syndrome: role of replacement fluids. Ann Neurol. 1987;22:753–761. doi: 10.1002/ana.410220612. [DOI] [PubMed] [Google Scholar]
  • 3.Guillain Barré Syndrome Study Group Plasmapheresis and acute Guillain-Barré syndrome. Neurology. 1985;35:1096–1104. doi: 10.1212/WNL.35.8.1096. [DOI] [PubMed] [Google Scholar]
  • 4.Henze T, Prange HW, Ritter G. Vegetative Funktionsstörungen bei schwer verlaufender Polyradikulitis Guillain-Barré-Strohl. Dtsch Wochenschr. 1986;111:1050–1054. doi: 10.1055/s-2008-1068581. [DOI] [PubMed] [Google Scholar]
  • 5.Keller AJ, Chirnside A, Urbaniak SJ. Coagulation abnormalities produced by plasma exchange on the cell separator with special reference to fibrinogen and platelet levels. Br J Haematol. 1979;42:593–603. doi: 10.1111/j.1365-2141.1979.tb01172.x. [DOI] [PubMed] [Google Scholar]
  • 6.Keller F, Schultze G, Offermann G, Molzahn M. Complications during therapeutic plasma exchange. Acute Care. 1985;11:100–105. [PubMed] [Google Scholar]
  • 7.Lisak RP, Abramsky O, Schotland D. Plasmapheresis in the treatment of myasthenia gravis: preliminary studies in 21 patients. In: Dau PC, editor. Plasmapheresis and the immunobiology of myasthenia gravis. Boston: Houghton Mifflin; 1979. pp. 209–215. [Google Scholar]
  • 8.Nau R, Behrends T, Henze T, Prange HW. ZNS-Infektion durch Aspergillus fumigatus. Eine Komplikation immunsuppressiver Therapie bei Myasthenia gravis. Nervenarzt. 1989;60:178–180. [PubMed] [Google Scholar]
  • 9.Nydegger U, Aeschbacher B. Pathophysiologische Aspekte und klinische Indikationen der Plasmaaustausch-Behandlung. Schweiz Med Wochenschr. 1987;117:1140–1151. [PubMed] [Google Scholar]
  • 10.Rodnitzky RL, Goeken JA. Complications of plasma exchange in neurological patients. Arch Neurol. 1982;39:350–354. doi: 10.1001/archneur.1982.00510180028007. [DOI] [PubMed] [Google Scholar]
  • 11.Shumak KH, Rock GA. Therapeutic plasma exchange. New Engl J Med. 1984;310:762–771. doi: 10.1056/NEJM198403223101206. [DOI] [PubMed] [Google Scholar]
  • 12.Sultan Y, Bussel A, Maisonneuve P. Potential danger of thrombosis after plasma exchange in the treatment of patients with immune disease. Transfusion. 1979;19:588–593. doi: 10.1046/j.1537-2995.1979.19580059816.x. [DOI] [PubMed] [Google Scholar]
  • 13.Sutton DMC, Cardella CJ, Uldall PR. Proceedings of the Haemonetics Research Institute Advanced Component Seminar. Boston: Haemonetics Research Center; 1979. Some observations on the complications of intensive plasma exchange. [Google Scholar]
  • 14.Sutton DMC, Nair RC, Rock G, the Canadian Apheresis Study Group Complications of plasma exchange. Transfusion. 1989;29:124–127. doi: 10.1046/j.1537-2995.1989.29289146829.x. [DOI] [PubMed] [Google Scholar]
  • 15.Wing EJ, Bruns FJ, Fraley DS, Segel DP, Adler S. Infectious complications with plasmapheresis in rapidly progressive glomerulonephritis. JAMA. 1980;244:2423–2426. doi: 10.1001/jama.1980.03310210025020. [DOI] [PubMed] [Google Scholar]
  • 16.Ziselman EM, Bongiovanni MB, Wurzel HA. The complications of therapeutic plasma exchange. Vox Sang. 1984;46:270–276. doi: 10.1111/j.1423-0410.1984.tb00086.x. [DOI] [PubMed] [Google Scholar]

Articles from Klinische Wochenschrift are provided here courtesy of Nature Publishing Group

RESOURCES